September 28, 2021
Diabetes or Obesity?
This morning Lilly announced they would be lowering the cost of insulin Lispro. Per a company issued press release;
“Lilly's Insulin Lispro Injection, 100 units/mL -- first introduced at half the list price of branded Humalog® (insulin lispro injection, 100 units/mL) in 2019 -- will now have a 70 percent lower list price than Humalog U-100 starting January 1, 2022”
We see three reasons Lilly made this move;
1. It’s great PR although we doubt it will make patient advocates happy who continue to believe the out-of-pocket cost of insulin is too high and likely . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
